Skip to main content

Market Overview

UPDATE: Morgan Stanley Initiates Aviv REIT with Equal-Weight on Balanced Risk-Reward

Share:

In a report published Monday, Morgan Stanley analyst Paul Morgan initiated coverage on Aviv REIT (NYSE: AVIV) with an Equal-Weight rating and $26.00 price target.

In the report, Morgan noted, “Aviv REIT completed its IPO on March 21st and with the stock up 22% since pricing, we see risk-reward as currently balanced and initiate with an Equal-weight rating and $26 price target. Despite the post-IPO run-up, our $1.44/share dividend expectation implies an attractive 5.9% yield (vs. 3.0% for the REIT sector). At a 35% premium to Net Asset Value, Aviv should be able to grow FFO accretively through acquisitions, as has been the company's track record as a private entity. We model $320M in SNF acquisitions at a 10% yield through 2014, driven by expanding relationships with Aviv's existing tenant base. We believe Aviv is positioned favorably relative to direct comp Omega Healthcare given lower leverage and asset base.”

Aviv REIT closed on Friday at $24.42.

Latest Ratings for AVIV

DateFirmActionFromTo
Feb 2015CitigroupMaintainsNeutral
Nov 2014RBC CapitalDowngradesOutperformSector Perform
Nov 2014SunTrust Robinson HumphreyDowngradesBuyNeutral

View More Analyst Ratings for AVIV
View the Latest Analyst Ratings

 

Related Articles (AVIV)

View Comments and Join the Discussion!

Posted-In: Morgan StanleyAnalyst Color Initiation Analyst Ratings

Latest Ratings

StockFirmActionPT
GOOGLMizuhoMaintains2,600.0
VZIOWells FargoInitiates Coverage On31.0
TWTROppenheimerMaintains85.0
SBUXOppenheimerMaintains135.0
OMWells FargoInitiates Coverage On63.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com